Showing 13,881 - 13,900 results of 113,423 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.59s Refine Results
  1. 13881

    Image_8_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  2. 13882

    Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  3. 13883

    Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  4. 13884

    Molecular Dynamics with Chemical AccuracyAlkane Adsorption in Acidic Zeolites by Fabian Berger (8813759)

    Published 2023
    “…They show that the observed decrease of experimental apparent barriers from propane to pentane for alkane cracking in MFI (28 kJ mol<sup>–1</sup>) is largely due to increasing adsorption strengths (21 kJ mol<sup>–1</sup>) and to a much smaller extent to decreasing intrinsic barriers (7 kJ mol<sup>–1</sup>).…”
  5. 13885

    Preclinical Evaluation of <sup>131</sup>I/<sup>18</sup>F‑Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging by Jianyang Fang (11301298)

    Published 2024
    “…The affinity and specificity of tracers were assessed through cell uptake and docking experiments, demonstrating that [<sup>131</sup>I]I-NFIP exhibited high specificity for STING, with a cell-based IC<sub>50</sub> value of 7.56 nM. …”
  6. 13886

    Preclinical Evaluation of <sup>131</sup>I/<sup>18</sup>F‑Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging by Jianyang Fang (11301298)

    Published 2024
    “…The affinity and specificity of tracers were assessed through cell uptake and docking experiments, demonstrating that [<sup>131</sup>I]I-NFIP exhibited high specificity for STING, with a cell-based IC<sub>50</sub> value of 7.56 nM. …”
  7. 13887
  8. 13888

    Design, Synthesis, and Biological Evaluation of New Peripheral 5HT<sub>2A</sub> Antagonists for Nonalcoholic Fatty Liver Disease by Minhee Kim (1592440)

    Published 2020
    “…Here, structural modifications of pimavanserin (CNS drug), a 5HT<sub>2A</sub> antagonist approved for Parkinson’s disease, led us to synthesize new peripherally acting 5HT<sub>2A</sub> antagonists. …”
  9. 13889

    Trends in ESR per survey round by age group. by Alex Daama (18351052)

    Published 2024
    “…Across the first three surveys, ESR prevalence was consistently higher among the married participants than the never married participants, aPR = 1.83, 95% CI: [1.30,2.57]; aPR = 2.46, 95% CI: [1.50,4.06]; aPR = 2.22, 95% CI: [1.22,4.03]. …”
  10. 13890
  11. 13891
  12. 13892
  13. 13893
  14. 13894
  15. 13895
  16. 13896
  17. 13897
  18. 13898
  19. 13899
  20. 13900